Why is Terumo Corp. ?
- Healthy long term growth as Net Sales has grown by an annual rate of 10.50%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 36.60
- The company has been able to generate a Return on Capital Employed (avg) of 11.11% signifying high profitability per unit of total capital (equity and debt)
- OPERATING CASH FLOW(Y) Highest at JPY 207,742 MM
- DEBT-EQUITY RATIO (HY) Lowest at -2.52 %
- RAW MATERIAL COST(Y) Fallen by -5.13% (YoY)
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -24.06%, its profits have risen by 10%
How much should you buy?
- Overall Portfolio exposure to Terumo Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Terumo Corp. for you?
Low Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at JPY 207,742 MM
Lowest at -2.52 %
Fallen by -5.13% (YoY
Highest at JPY 426,442 MM
Highest at 5.58%
Highest at JPY 74,669 MM
Highest at 28.72 %
Highest at JPY 55,480 MM
Highest at JPY 41,843 MM
Highest at JPY 28.36
At JPY 3,701 MM has Grown at 99.62%
Lowest at 1.56%
Here's what is working for Terumo Corp.
Operating Cash Flows (JPY MM)
Debt-Equity Ratio
Operating Profit (JPY MM)
Operating Profit to Sales
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
EPS (JPY)
Cash and Cash Equivalents
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Terumo Corp.
Interest Paid (JPY MM)
Inventory Turnover Ratio






